← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Azevan Pharmaceuticals, Inc.
Bethlehem, PA
$16,392,492
Total funding
9
Grants
Funding over time
peak $3.2M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$16,392,492 · 9
By mechanism
R44$9,416,156 · 3
U44$5,635,109 · 1
R43$501,472 · 1
R42$498,684 · 1
R41$341,071 · 3
Investigators at Azevan Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Advancing SRX246 to Commericialization$3,190,881
R44 · FY2020 · NS
Tolerability of SRX246 in Huntington's Disease Patients$2,214,354
U44 · FY2016 · NS
Tolerability of SRX246 in Huntington's Disease Patients$1,480,173
U44 · FY2017 · NS
Tolerability of SRX246 in Huntington's Disease Patients$1,115,185
U44 · FY2015 · NS
A Potential New Drug for Depression$801,007
R44 · FY2007 · MH
A Potential New Drug for Depression$797,078
R44 · FY2008 · MH
A Potential New Drug for Depression$795,315
R44 · FY2009 · MH
Tolerability of SRX246 in Huntington's Disease Patients$764,163
U44 · FY2018 · NS
New Drugs for Stress-related Affective Illness$600,000
R44 · FY2011 · MH
New Drugs for Stress-related Affective Illness$598,813
R44 · FY2013 · MH
New Drugs for Stress-related Affective Illness$595,262
R44 · FY2012 · MH
A New Drug for the Treatment of Traumatic Brain Injury$501,472
R43 · FY2019 · NS
A New Drug for Depression$449,093
R44 · FY2006 · MH
A New Drug for Depression$449,073
R44 · FY2005 · MH
A New Drug for Depression$449,054
R44 · FY2004 · MH
New Drugs for Stress-related Affective Illness$349,195
R44 · FY2010 · MH
Treating Self-Abuse in Autism and Mental Retardation$250,019
R42 · FY2002 · HD
Treating Self-Abuse in Autism and Mental Retardation$248,665
R42 · FY2003 · HD
A Potential New Drug for Depression$226,385
R44 · FY2009 · MH
Screening New Therapeutics for the Treatment of Post Traumatic Stress Disorder$141,071
R41 · FY2011 · MH